Editor’s Note: Morningstar has acquired the Center for Research in Security Prices, the provider of the index tracked by this ...

The Vanguard Group of Valley Forge, Pa., is beloved for its low-cost, index investment strategy. The firm offers nearly two dozen exchange-traded funds (ETFs) with expense ratios of only 0.03%. Here ...

While the exchange traded funds (ETF) market may be booming investors are being warned to not chase market performance as international ETFs have received significant inflows off the back of recent ...

XRP ETFs saw mixed performance on January 28, with XRPC, XRPZ, and GXRP recording inflows, while TOXR and XRP remained stable ...

Data from Ace MF shows Indian silver exchange-traded funds (ETFs) reported spectacular gains with one-year returns of more than 270 percent and three-year gains near 70 percent across most funds ...

The ProShares Ultra Gold ETF offers 2x daily leveraged exposure to the Bloomberg Gold Subindex, with high liquidity and intensive short-term trading activity. UGL's performance diverges from ...

The Invesco Aerospace & Defense ETF is a well-established U.S. Aerospace & Defense ETF tracking the SPADE Defense Index. Its expense ratio is 0.58%, and the fund currently has $6.5B in assets under ...

Each month, we check in on the performance of the largest US stock, bond, and active exchange-traded funds. The Morningstar US Market Index fell 0.03% during December and is up 17.35% over the past ...

Discover the top ETFs to watch in 2026, and learn how to trade them using CFDs with IG Singapore. This article also explores different ETF types, risks, and key market trends. ETFs let traders access ...

Launched on February 17, 2011, the First Trust Indxx NextG ETF (NXTG) is a passively managed exchange traded fund designed to provide a broad exposure to the Technology - Telecom segment of the equity ...

Commodity-focused and equity precious metals ETFs topped the list in a year where the majority posted positive performance.

Eli Lilly And Co (NYSE: LLY) has officially become the giant quietly moving the strings behind a large slice of the pharma ETF universe. With blockbuster revenue growth, repeated earnings beats and a ...